To refine your search through our archives use our Advanced Search
Less than 20% of the monoclonal antibody doses shipped by two companies, Indianapolis-based Lilly and New York-based Regeneron, have have used, officials say, even though they can reduce hospitalizations by up to 70%.
Indiana has reported an increase of 1,472 deaths from COVID-19 since the beginning of the month, just two fewer than the increase of deaths reported in all of November.
In Indiana, the health department recently said it would no longer ask for a detailed list of symptoms and would encourage people to call their own contacts.
The breakthrough came after two days of scrambling that sent tremors across Capitol Hill, as lawmakers realized that a deal badly desired by both sides could fall through at the last minute.
The state on Saturday reported 73 more deaths due to COVID-19, the 10th time deaths have exceeded 70 in the past 12 daily reports.
Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health.
Red tape, staff shortages, testing delays and strong skepticism are keeping many patients and doctors from the drugs made by Eli Lilly and Co. and Regeneron Pharmaceuticals.
The Food and Drug Administration was evaluating a shot developed by Moderna Inc. and the National Institutes of Health and was expected to give it the green light soon, clearing the way for its use to begin as early as Monday.
Sen. John Thune, R-S.D., the No. 2 Senate Republican, told reporters Friday afternoon that expectations of a deal by the end of the day reflected “a triumph of hope over experience.”
As the coronavirus sidelines huge numbers of educators, school districts are turning to college students, who are learning online or home for extended winter breaks.
When you send an email, how long does it take to get a response? It can be frustrating to sit around, waiting to hear back.
Christmas trees were first used to decorate Monument Circle in 1918, and the practice expanded after World War II.
The greater Indianapolis region is a major hub for goods movement, which is a huge asset for attracting and growing companies whose goal is to cover the broader U.S. market.
An extended grace period and broadened scope would help states and communities develop new, forward-looking strategies to thrive in the long term, not just the short-term emergency.
Greg Morris will undoubtedly continue his excellent service to our great city, perhaps through using his talent and experience with a not-for-profit organization and its worthwhile mission or in a role with the government.
The Engage Indiana discussion proved to be a powerful primer on how to actually fix some of our community’s most vexing problems.
Officials are leaning toward choosing a path that cuts through the property of a major employer, in order to avoid the route that would pass through a historic district. The employer is threatening to leave the city.
Hendricks Commercial Properties has begun preliminary discussions on phase two, but hasn’t decided whether to stick with its original plan that emphasized office space.
Several state lawmakers have been drafting coronavirus immunity legislation over the past several months as efforts in Congress to pass federal legislation have stalled.
The usual plan, which involves packing people closely on as many cots and mats as Wheeler Mission’s shelters can hold, isn’t an option under social distancing guidelines.
